Press Releases

9/16/2008 Javelin Pharmaceuticals Completes Patient Enrollment for Second of two Pivotal Phase 3 Studies of Dyloject(TM)	9.8 KB
8/26/2008 Javelin Pharmaceuticals CEO to Provide Corporate Overview at the BioCentury NewsMakers Conference	8.0 KB
8/21/2008 Javelin Presents Successful Pivotal Phase 3 Secondary Clinical Results for Dyloject(TM) at the 12th World Congress on Pain	10.6 KB
8/12/2008 Javelin Presents PMI-150 (Intranasal Ketamine) Data at Premier Department of Defense Scientific Meeting	11.9 KB
8/11/2008 Javelin Pharmaceuticals, Inc. to Present at 28th Annual Canaccord Adams Global Growth Conference in Boston	9.1 KB
8/7/2008 Javelin Pharmaceuticals, Inc. Reports Second Quarter 2008 Results and Corporate Highlights	13.7 KB
8/1/2008 Javelin Pharmaceuticals to Announce Second Quarter 2008 Financial Results	8.5 KB
7/31/2008 Javelin Pharmaceuticals and Baxter Healthcare Corporation Expand Commercial Supply Relationship for Anticipated Dyloject(TM) Global Growth	9.5 KB
6/10/2008 Javelin Pharmaceuticals Enrolls First Patient in Pivotal Trial for PMI-150	9.9 KB
6/5/2008 Javelin Pharmaceuticals' Founder and President Transitions to Executive Director	7.3 KB
6/4/2008 Javelin Pharmaceuticals, Inc. Announces New Patent Covering PMI-150 (Intranasal Ketamine)	9.3 KB
5/14/2008 Javelin Pharmaceuticals, Inc. Reports First Quarter 2008 Results	12.5 KB
5/9/2008 Javelin Pharmaceuticals to Announce First Quarter 2008 Financial Results	7.5 KB
5/8/2008 Javelin Pharmaceuticals, Inc. to Raise $27.6 Million through Registered Direct Offering	6.7 KB
4/16/2008 Javelin Pharmaceuticals Appoints John C. Taylor as Vice President of Business Development	8.5 KB
4/1/2008 Javelin CEO to Present at the 8th Annual Fortis Biotechnology Conference	7.0 KB
3/14/2008 Javelin Pharmaceuticals CEO to Present at Cowen & Company's 28th Annual Health Care Conference	8.0 KB
3/10/2008 Javelin Pharmaceuticals' Dyloject Accepted by Scottish Medicines Consortium (SMC)	9.7 KB
3/6/2008 Javelin Pharmaceuticals Reports Results for the Year Ended 2007	13.0 KB
3/4/2008 Javelin Pharmaceuticals Board Appoints Industry Veteran Martin Driscoll as Chief Executive Officer	10.4 KB
Showing 41-60 of 156 releases Page: 1 2 3 4 5 6 7 8  See Previous 20 | See Next 20

CONTACT US   JOIN US   SITE MAP
© 2010 Javelin Pharmaceuticals,Inc. / Intrac,Inc. / IDDS,Inc. All rights reserved. All other trademarks are the properties of their respective owners. Reproduction in whole or in part in any form or medium without express written permission of Javelin Pharmaceuticals,Inc. / Intrac,Inc. /IDDS,Inc. is prohibited.